Albertsons Cos. announced that more than 1,600 of its pharmacies across 21 states have pharmacists with the ability to independently provide naloxone, a medication used to reverse the impacts of an opioid overdose, and to educate patients and caregivers about its use.
Soleo Health, an innovative leader in specialty infusion services, announced the company has been selected by Genentech (member of the Roche Group), a world-leading biotechnology company with multiple products on the market and a strong development pipeline, to dispense two limited distribution drug
Rite Aid Corp. announced that starting Sunday, July 1, Rite Aid pharmacists at all locations in Idaho will be able to prescribe medications to treat select, common conditions, under the Pharmacist Prescriptive Authority Rule Docket 27-0104-1701 promulgated by the Idaho State Board of Pharmacy.
Kimberly-Clark Corp. has reported its progress toward achieving its Sustainability 2022 strategy to create social, environmental and business value.
HeadBlade, a leader in HeadCare and developers of the ultimate head shaving razor, the HeadBlade MOTO, announced Tom Wainman, formerly a pitchman for Hair Club for Men, as its new spokesperson.
AcneFree announces its support of the American Acne and Rosacea Society (AARS), a non-profit organization, as a part of its commitment to better educate the 21 million teenagers in the U.S. – approximately 80% of all teens – who suffer from acne and occasional breakouts.
Upsher-Smith Laboratories (Upsher-Smith) announced that it will be featuring Platinum Pass, the latest addition to the Access Pathways Program for Qudexy XR (topiramate) extended-release capsules at the 60th Annual Scientific Meeting of the American Headache Society (AHS), June 28 to July 1, in
MinuteClinic, the retail medical clinic of CVS Health, is encouraging unvaccinated Ohio residents to receive the hepatitis A vaccine following an increase in confirmed cases of the virus.
SAN FRANCISCO – McKesson Ventures, the venture capital arm of McKesson Corporation, announced that it has donated $10,000 to Meals on Wheels America on behalf of its former portfolio company Landmark Health, a leading provider of in-home, risk-based medical care.
Genentech announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose, oral treatment for acute, uncomplicated influenza in people 12 years and older.
The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, that begin in childhood but can persist in adulthood.
Aurobindo Pharma announced that the company has received final approval from the U.S. Food & Drug Administration to manufacture and market ertapenem injection 1 g/vial. Aurobindo’s ertapenem injection is a generic equivalent of Merck Sharp & Dohme Corp’s Invanz Injection.
Starting next month, Dove will be taking another step in ensuring beauty is a source of confidence and not anxiety with the launch of a ‘No Digital Distortion Mark’. The Mark will roll out across all branded content globally beginning in July with deodorant campaigns leading the initiative.
Dove Chocolate is hosting the first-ever Cocoa Farmers Market at Santa Monica Place in Los Angeles, an interactive experience detailing the chocolate-making journey from bean to bar.
Earlier this year, Harmony Herbal introduced Skin Therapy Calm and Calm + Detox, said to be the first herbal medicine-based supplement and topical combination duo to relieve the symptoms of rash, eczema and dermatitis with a whole body wellness approach.
Rite Aid Corp. today announced that the registration statement on Form S-4, in connection with its proposed merger with Albertsons Cos., has been declared effective by the U.S. Securities and Exchange Commission (SEC).
